Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 17, 2023
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
Elemer Piros Reiterated (UNCY) at Strong Buy and Held Target at $5 on, May 17th, 2023
Elemer Piros of EF Hutton, Reiterated "Unicycive Therapeutics, Inc." (UNCY) at Strong Buy and Held Target at $5 on, May 17th, 2023.
Elemer has made no other calls on UNCY in the last 4 months.
There are 2 other peers that have a rating on UNCY. Out of the 2 peers that are also analyzing UNCY, 0 agree with Elemer's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Elemer
- Bruce Jackson of "Benchmark" Maintained at Buy with Decreased Target to $3 on, Friday, April 21st, 2023
- Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $6 on, Thursday, March 9th, 2023
